Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
27.7M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
669K
-
Shares change
-
+514K
-
Total reported value, excl. options
-
$3.39M
-
Value change
-
+$2.6M
-
Number of buys
-
11
-
Price
-
$5.06
Significant Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (MRIC) as of Q3 2019
14 filings reported holding MRIC - ClearPoint Neuro, Inc. - Common Stock, $0.01 par value as of Q3 2019.
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (MRIC) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 669K shares
of 27.7M outstanding shares and own 2.41% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (244K shares), MILLENNIUM MANAGEMENT LLC (115K shares), Merriman Wealth Management, LLC (73.7K shares), BANK OF AMERICA CORP /DE/ (50.8K shares), KIRR MARBACH & CO LLC /IN/ (43.2K shares), GOLDMAN SACHS GROUP INC (33.2K shares), BROWN ADVISORY INC (28K shares), PARSONS CAPITAL MANAGEMENT INC/RI (26.6K shares), Williams Jones Wealth Management, LLC. (21.6K shares), and WESTWOOD MANAGEMENT CORP /IL/ (17.5K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.